Monitoring of Immune and Microbial Reconstitution in (HCT) and Novel Immunotherapies
| Status: | Recruiting |
|---|---|
| Conditions: | Infectious Disease, Hematology |
| Therapuetic Areas: | Hematology, Immunology / Infectious Diseases |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 9/28/2018 |
| Start Date: | September 21, 2018 |
| End Date: | January 2030 |
| Contact: | Timothy Krepsky, RN |
| Email: | tkrepsk1@fairview.rog |
| Phone: | 612-273-2800 |
Monitoring of Immune and Microbial Reconstitution in Hematopoietic Cell Transplantation (HCT) and Novel Immunotherapies
This protocol serves as a mechanism to collect, store, and distribute bodily fluid and tissue
samples obtained from Hematopoietic Cell Transplant (HCT) or novel immunotherapy patients and
their donors at the Masonic Cancer Center in order to conduct correlative studies of the
immune system, microbiota, and their interactions. Fluid (including but not limited to,
blood, urine, saliva, cerebrospinal fluid, bronchoalveolar lavage fluid) sample log-in,
processing, relabeling, and storage is performed by the Masonic Cancer Center (MCC)
Translational Therapy Lab (TTL).
samples obtained from Hematopoietic Cell Transplant (HCT) or novel immunotherapy patients and
their donors at the Masonic Cancer Center in order to conduct correlative studies of the
immune system, microbiota, and their interactions. Fluid (including but not limited to,
blood, urine, saliva, cerebrospinal fluid, bronchoalveolar lavage fluid) sample log-in,
processing, relabeling, and storage is performed by the Masonic Cancer Center (MCC)
Translational Therapy Lab (TTL).
Inclusion Criteria:
- Patients planning to undergo HCT or other cellular therapy/immunotherapy
- Allogeneic related donors
- Aged 0-80
- Willing and able to sign voluntary written consent
Exclusion Criteria:
- Patients whose medical record indicates that they have opted out of research
We found this trial at
1
site
Click here to add this to my saved trials
